A 66-year-old man with prostate cancer had his tumor removed without the surgeon ever stepping into his operating room. Dr.
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...
Dr. Kishore T. A , Senior Consultant, Uro Oncology & Transplant Surgery, Aster Medcity Kochi | A major 1,500-case experience ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer / cancer, cancer care, Cancer ...
September is Prostate Cancer Awareness Month -- a reminder for men to talk with their doctors about getting screened. It's the #1 cancer in men and the second deadliest. A simple blood test can detect ...
Why doesn’t my doctor automatically order a PSA test to screen for prostate cancer? Shouldn’t all men be tested regularly? With over 330,000 new cases estimated for 2026, prostate cancer accounts for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results